To study the problem of drug interactions in an emergency department, a microcomputer was programmed to identify the potentially adverse enhancements and antagonistic interactions of drugs in a randomly chosen group of 355 patients who were currently taking or were administered two or more medicatio
β¦ LIBER β¦
The Low Potential for Drug Interactions with Zanamivir
β Scribed by Mr Mick J. Daniel, Jacqueline M. Barnett, Bridget A. Pearson
- Book ID
- 120803822
- Publisher
- Springer International Publishing AG
- Year
- 1999
- Tongue
- English
- Weight
- 132 KB
- Volume
- 36
- Category
- Article
- ISSN
- 0312-5963
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The potential for drug interactions
β
Stephen Karas Jr
π
Article
π
1981
π
Elsevier Science
π
English
β 295 KB
(168) Milnacipran has low potential for
β
A. Periclou; S. Coutts; S. Rao; R. Palmer
π
Article
π
2008
π
Elsevier Science
π
English
β 44 KB
(851): Lacosamide has low potential for
β
D. Kropeit; U. Scharfenecker; B. Schiltmeyer; B. Koch; D. Rudd; W. Cawello; R. H
π
Article
π
2006
π
Elsevier Science
π
English
β 39 KB
(752): Low potential for drug-drug-inter
β
D. Thomas; U. Scharfenecker; B. Schiltmeyer; W. Cawello; P. Doty; R. Horstmann
π
Article
π
2007
π
Elsevier Science
π
English
β 42 KB
Interaction of zanamivir with DNA and RN
β
Shohreh Nafisi; Fatemeh Ghoreyshi Kahangi; Ebrahim Azizi; Nader Zebarjad; Heidar
π
Article
π
2007
π
Elsevier Science
π
English
β 459 KB
Zanamivir (ZAN) is the first of a new generation of influenza virus-specific drugs known as neuraminidase inhibitors, which acts by interfering with life cycles of influenza viruses A and B. It prevents the virus spreading infection to other cells by blocking the neuraminidase enzyme present on the
Potential drug interactions with cyclosp
β
H. Irving Katz
π
Article
π
1997
π
John Wiley and Sons
π
English
β 582 KB